Telemedicine Adoption And Chronic Care Expansion Will Reshape Markets
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 8 Analysts
Published
21 Aug 25
Updated
21 Aug 25
AnalystHighTarget's Fair Value
US$18.00
64.8% undervalued intrinsic discount21 Aug
US$6.33
1Y
16.1%7D
-1.6%